Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Girona
Clinical trial register · Spain

Clinical Trials in Girona, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca17 Merck Sharp & Dohme LLC16 Fundación GECP9 Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta9 Janssen Research & Development, LLC8
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Girona

213 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Immersive VR to Reduce Stress, Anxiety, and Pain During PICC/Midline Placement
NCT07696156Vasoconstriction, Biomarkers, Central Venous Catheters, Midline Catheter
DrugChlorhexidine Gluconate
diana garcia
Not applicable
202
Barcelona, Manresa, Girona
2027-01-15
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Santander, Santiago de Compostela, Barcelona, Coslada, Girona, Madrid, Málaga, Oviedo
2026-12-16
Recruiting
Corbus Pharmaceuticals Inc.
Phase 3
260
Barcelona, Madrid, Girona, Seville, Valencia, Zaragoza
2026-09-29
Recruiting
AstraZeneca
Phase 3
2,800
Badajoz, Barcelona, Córdoba, Girona, Madrid, Majadahonda, Talavera de la Reina, Valencia
2026-09-01
Recruiting
Clinical Investigation to Validate the Safety and Performance of the ABLE Kids Device in Pediatric Patients With Neurological Gait Disorders in a Clinical Setting
NCT07745712Gait Impairment, Cerebral Palsy (CP), Neuromuscular Diseases (NMD), Spinal Cord Injuries (SCI)
ABLE Human Motion S.L.
Not applicable
15
Girona
2026-09-01
Not yet open
Hospital Universitari Vall d'Hebron Research Institute
Phase 3
15,160
Granada, Barcelona, Girona, Tarragona, Barakaldo, A Coruña, Alicante, Burgos
2026-07-01
Recruiting
Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum
NCT07342608Bradycardia, Left Bundle Branch Area Pacing, Left Bundle Branch Pacing
MicroPort CRM
Not applicable
450
Girona, Granada, Valencia
2026-06-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Girona, Valencia, Barcelona, Madrid, Seville
2026-06-18
Recruiting
Eikon Therapeutics
Phase 2/3
750
Jerez de la Frontera, Castellon, Barcelona, Girona, Málaga
2026-06-15
Recruiting
Fundacion Clinic per a la Recerca Biomédica
Phase 2
90
Badalona, Barcelona, Santander, Córdoba, Girona, Madrid, Puerto de la Torre, Valencia
2026-06-02
Recruiting
Novo Nordisk A/S
Phase 3
2,500
A Coruña, Antequera, Barcelona, Centelles (Barcelona), Girona, Madrid, Manresa, Málaga
2026-05-21
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Alicante, Barcelona, Ferrol, Gijón, Girona, Madrid, Navarra, Santiago de Compostela
2026-04-21
Recruiting
Novo Nordisk A/S
Phase 2
270
La Roca Del Vallés, A Estrada, Barcelona, Castilleja de la Cuesta, Girona, Santiago de Compostela
2026-04-17
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
118
Badajoz, Badalona, Barcelona, Girona, Madrid, Manresa, Seville, Valencia
2026-03-31
Recruiting
Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer
NCT07195227Hormon Receptor Positive Breast Cancer, Breast Cancer
DrugsCamizestrant·Ribociclib
MedSIR
Phase 2
150
Alicante, Barcelona, Girona, Granada, Jerez de la Frontera, León, Madrid, Málaga
2026-03-24
Recruiting
Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial
NCT07193927MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Fatty Liver Disease, Nonalcoholic, Overweight (BMI > 25)
AB Biotics, SA
Phase 2
60
Girona
2026-03-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
400
Las Palmas de Gran Canaria, Girona, Majadahonda, Barcelona, Madrid, Málaga, Seville
2026-03-18
Recruiting
Instituto de Investigación Biomédica de Salamanca
Phase 3
300
Salamanca, Almería, Barakaldo, Girona, Las Palmas de Gran Canaria, Madrid, Murcia, Santander
2026-03-01
Recruiting
SOLTI Breast Cancer Research Group
Phase 2
300
Barcelona, A Coruña, Alicante, Badajoz, Bilbao, Girona, Granada, L'Hospitalet de Llobregat
2026-02-18
Recruiting
Boehringer Ingelheim
Phase 3
1,325
A Coruña, Alicante, Barakaldo, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Salamanca
2026-02-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Girona, A Coruña, Madrid, Valencia, Barcelona, Córdoba
2026-02-16
Recruiting
ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure
NCT07484009Acute Heart Failure (AHF), Heart Failure (for Example, Fluid Overload), Heart Failure Hospitalization
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Not applicable
1,014
Madrid, Barcelona, Córdoba, Girona, Málaga, Murcia, Salamanca, Sant Joan Despí
2026-01-29
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Girona, Valencia, Barcelona, Córdoba, Madrid
2026-01-19
Recruiting
Institut d'Investigació Biomèdica de Bellvitge
Phase 4
64
L'Hospitalet de Llobregat, Barcelona, Girona, Granada
2026-01-14
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Santiago de Compostela, Elche, Granada, Seville, Barcelona, L'Hospitalet de Llobregat, Jerez de la Frontera, Girona
2026-01-06
Recruiting
AstraZeneca
Phase 3
1,100
A Coruña, Badalona, Barcelona, Córdoba, Donostia / San Sebastian, Girona, L'Hospitalet de Llobregat, Madrid
2025-12-29
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Badajoz, Badalona, Barakaldo, Barcelona, Córdoba, Elche, Girona, Hospitalet
2025-12-12
Recruiting
Hospital Universitari Vall d'Hebron Research Institute
Not applicable
750
Barcelona, A Coruña, Alicante, Cabueñes, Cadiz, Elche, Getafe, Girona
2025-12-04
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Valencia, Barcelona, Elche, Girona, Jerez de la Frontera, Madrid, Málaga, Pamplona
2025-11-30
Recruiting
Genmab
Phase 3
660
Palma de Mallorca, Barcelona, Girona, A Coruña, Madrid, Málaga, Pamplona, Valencia
2025-11-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
L'Hospitalet de Llobregat, Santander, Girona, Madrid, Valencia, Barcelona, Córdoba
2025-11-26
Active, closed
Universitat de Girona
Not applicable
29
Girona
2025-11-22
Recruiting
AbbVie
Phase 2
400
Santander, Donostia / San Sebastian, Las Palmas de Gran Canaria, Majadahonda, Seville, A Coruña, Barcelona, Girona
2025-11-13
Recruiting
Incyte Corporation
Phase 2
160
Barcelona, Córdoba, Girona, Madrid, Murcia, Valencia
2025-11-12
Recruiting
Boehringer Ingelheim
Phase 3
670
A Coruña, Barcelona, Girona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Palma de Mallorca
2025-11-07
Recruiting
CatalYm GmbH
Phase 2
131
Jaén, Málaga, Seville, Barcelona, Santiago de Compostela, Girona, Logroño, Madrid
2025-10-07
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Barcelona, Gijón, Girona, Madrid, Santiago de Compostela, Seville, Valencia
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Barcelona, Ferrol, Galdakao, Gijón, Girona, Madrid, Santiago de Compostela, Seville
2025-10-01
Active, closed
University Rovira i Virgili
Not applicable
108
Barcelona, Girona, Tarragona
2025-09-15
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Badajoz, Badalona, Barcelona, Castellon, Cáceres, El Palmar, Girona, Huelva
2025-08-26
Recruiting
AstraZeneca
Phase 3
700
Barcelona, Girona, Madrid, Majadahonda, Málaga, Oviedo, Sabadell, Santander
2025-08-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Barcelona, Girona, Valencia
2025-08-05
Recruiting
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Observational
100
Girona
2025-08-05
Recruiting
PALACE: Cemiplimab Trial According to ctDNA Levels
NCT06917573Non Small Cell Lung Cancer Metastatic, Lung Diseases, Stage IV Non-small Cell Lung Cancer, Stage III Non-small Cell Lung Cancer
DrugsCarboplatine·Cemiplimab·Paraplatin·Taxol
Fundación GECP
Phase 2
63
Alicante, Elche, Badalona, Barcelona, L'Hospitalet de Llobregat, Bilbao, Jerez de la Frontera, Girona
2025-07-29
Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
NCT06858319Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
220
Girona
2025-07-28
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
A Coruña, Badalona, Barcelona, Girona, Madrid, Málaga, Seville
2025-07-17
Recruiting
Fundación GECP
Phase 2
97
Alicante, Badalona, Barcelona, Bilbao, Jerez de la Frontera, Girona, Granada, A Coruña
2025-07-08
Recruiting
NORCE Norwegian Research Centre AS
Not applicable
600
Barcelona, Girona
2025-07-01
Recruiting
Novo Nordisk A/S
Phase 2
200
Granada, Girona, El Palmar, Barcelona, Denia, Las Palmas de Gran Canaria, Madrid, Majadahonda
2025-06-30
Recruiting
MedSIR
Phase 2
200
Barcelona, Cáceres, Girona, Granada, Jaén, Madrid, Majadahonda, Murcia
2025-06-30
Recruiting
MedSIR
Phase 2
20
Elche, Barcelona, Girona, Madrid, Reus, Alicante, Barakaldo, León
2025-06-27
Recruiting
PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML
NCT06409936CML, Chronic Phase, Chronic Myeloid Leukemia, Chronic Phase, Chronic Myeloid Leukemia, BCR/ABL-Positive, Chronic Myeloid Leukemia
DrugsAsciminib·Nilotinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
160
Barcelona, Bilbao, Girona, Granada, Las Palmas de Gran Canaria, Madrid, Murcia, Salamanca
2025-06-26
Recruiting
BioNTech SE
Phase 3
480
Barcelona, Córdoba, Donostia / San Sebastian, Girona, Madrid, Valencia
2025-06-10
Recruiting
Chronic Insomnia in Non-Cancer Pain Patients
NCT07057232Chronic Non-cancer Pain, Insomnia
Germans Trias i Pujol Hospital
Observational
385
Badalona, Barcelona, Girona, Hospitalet Del Llobregat, Lleida, Sant Joan Despí, Tarragona, Terrassa
2025-06-09
Recruiting
Boehringer Ingelheim
Phase 3
1,755
A Coruña, Badalona, Barcelona, El Palmar, Girona, Huelva, Jerez de la Frontera, L'Hospitalet de Llobregat
2025-06-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
L'Hospitalet de Llobregat, Girona, Barcelona, Córdoba, Madrid, Valencia
2025-05-22
Recruiting
Eikon Therapeutics
Phase 2/3
740
Santiago de Compostela, Badalona, Barcelona, Santander, Cáceres, Lugo, Girona, Madrid
2025-05-22
Recruiting
Corxel Pharmaceuticals
Phase 2/3
740
A Coruña, Albacete, Barcelona, Girona, Madrid, Málaga, Seville, Valencia
2025-05-15
Recruiting
Evaluation of an Integrated Home Care Model
NCT07408882Older Adults (70 or More) Living at Home With Health and Social Complexity
Parc Sanitari Pere Virgili
Not applicable
1,000
Barcelona, Girona, Olot, Vic
2025-05-15
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
DrugsVinblastine·Methotrexate·Doxorubicin·Durvalumab
AstraZeneca
Phase 2
150
Barcelona, Girona, Las Palmas de Gran Canaria, Lugo, Madrid, Santiago de Compostela
2025-05-15
Recruiting
Biogen
Phase 3
454
Viladecans, Barcelona, A Coruña, Alcorcón, Getafe, Cáceres, Girona, Madrid
2025-05-08
Recruiting
Joseph Broderick, MD
Phase 3
350
Badalona, Horta, L'Hospitalet de Llobregat, Barcelona, Girona, Lleida, Valladolid
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Alicante, Barcelona, Girona, Lleida, Madrid, Palma de Mallorca, Tarragona, Valencia
2025-05-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Girona, Madrid, Valencia, Barcelona, Córdoba
2025-04-09
Recruiting
Gilead Sciences
Phase 3
695
A Coruña, Barcelona, Girona, Jaén, Las Palmas de Gran Canaria, Madrid, Málaga, Seville
2025-04-04
Recruiting
The Pivotal Study of RapidPulseTM Aspiration System
NCT06029491Acute Ischemic Stroke
RapidPulse, Inc
Not applicable
170
Alicante, Badalona, Barcelona, Girona, Madrid
2025-03-27
Recruiting
Consorci Sanitari de l'Alt Penedès i Garraf
Observational
450
Badalona, Sant Pere de Ribes, Barcelona, Girona
2025-03-20
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
A Coruña, Barcelona, Girona, Madrid, Seville, Valladolid, Zaragoza
2025-03-14
Active, closed
An Ophthalmic Safety Study in Patients With Breast Cancer
NCT06767462Ophthalmic Safety in Patients With Breast Cancer
AstraZeneca
Observational
160
Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Leganés, Madrid, Majadahonda, Salamanca
2025-03-05
Recruiting
Menarini Group
Phase 2
44
Barcelona, Cadiz, Girona, Madrid, Málaga, Santiago de Compostela
2025-02-18
Recruiting
Probelte Pharma S.L.U.
Observational
27
Barcelona, Castellon, Ciudad Real, Córdoba, Girona, Lleida, Madrid, Orihuela
2025-02-01
Active, closed
AstraZeneca
Phase 3
101
Alicante, Barcelona, Bilbao (Vizcaya), Córdoba, Donostia / San Sebastian, El Palmar, Girona, Madrid
2025-01-07
Active, closed
AstraZeneca
Phase 3
45
A Coruña, Alicante, Barakaldo, Barcelona, Córdoba, El Palmar, Girona, L'Hospitalet de Llobregat
2024-12-30
Active, closed
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Phase 2
28
Palma de Mallorca, Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Lleida, Tarragona, Terrassa
2024-12-16
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Barcelona, Elche, Girona, Madrid, Pamplona, Vigo, Zaragoza
2024-12-13
Recruiting
Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
NCT06180356Ovarian Cancer, Oligometastatic Disease, Serous Ovarian Tumor
DrugNiraparib
MedSIR
Phase 2
30
A Coruña, Barakaldo, Barcelona, Girona, Jaén, Madrid, Málaga, Oviedo
2024-12-03
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Endometrioid Ovarian Cancer
DrugsTORL-1-23·Pegfilgrastim
TORL Biotherapeutics, LLC
Phase 2
230
Girona
2024-11-20
Active, closed
Sanofi
Phase 2
556
Santiago de Compostela, Badalona, Santander, Barcelona, Madrid, Benalmádena, Girona, Málaga
2024-11-07
Recruiting
Fundación GECP
Observational
50
Ferrol, Alicante, Badalona, Barcelona, Bilbao, Ciudad Real, Girona, A Coruña
2024-10-03
Recruiting
Colorado Prevention Center
Phase 3
2,600
Girona, A Coruña, Santiago de Compostela, Madrid, Majadahonda, Málaga, Manises, Valencia
2024-08-20
Recruiting
AstraZeneca
Phase 3
1,018
Barcelona, El Palmar, Girona, Las Palmas de Gran Canaria, Madrid, Oviedo, Pamplona, Santander
2024-08-07
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Barcelona, Elche, Girona, Granada, Jaén, León, Madrid, Majadahonda
2024-07-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Barcelona, L'Hospitalet de Llobregat, Girona, Madrid, Valencia, Córdoba
2024-07-24
Recruiting
Daiichi Sankyo
Phase 1/2
123
Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville, Vigo
2024-07-22
Recruiting
GlaxoSmithKline
Phase 1
675
Barcelona, Córdoba, Girona, Madrid, Pozuelo de AlarcOn Madr
2024-07-02
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Barcelona, Córdoba, Girona, Madrid, Pamplona, Salamanca, Seville
2024-06-19
Recruiting
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Not applicable
40
Girona
2024-06-15
Active, closed
Exelixis
Phase 2/3
600
A Coruña, Barcelona, Girona, Madrid, Pamplona, Seville, Valencia, Zaragoza
2024-06-07
Recruiting
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Phase 3
57
Girona
2024-06-01
Recruiting
CSL Behring
Phase 2/3
3,110
Alcobendas, Barcelona, Córdoba, Girona, Granada, Guadalajara, Lleida, Madrid
2024-04-27
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Badalona, El Palmar, Oviedo, Cáceres, Girona, Las Palmas de Gran Canaria, Salamanca, Valencia
2024-04-22
Active, closed
MedSIR
Phase 2
976
A Coruña, Alicante, Barcelona, Bilbao, Castellon, Córdoba, Elche, Girona
2024-04-01
Active, closed
Fundación EPIC
Not applicable
40
Barcelona, Girona, L'Hospitalet de Llobregat
2024-03-20
Active, closed
GlaxoSmithKline
Phase 4
336
Barcelona, Girona, Valencia
2024-03-20
Recruiting
Pfizer
Phase 3
492
Badalona, Terrassa, Barakaldo, Barcelona, Murcia, Girona, Valencia, Madrid
2024-02-08
Recruiting
Fernandez Zamora
Not applicable
148
Girona
2024-02-05
Recruiting
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Not applicable
60
Girona
2024-02-01
Active, closed
RECORDATI GROUP
Phase 2
93
Barcelona, Córdoba, Girona, Madrid
2024-01-04
Active, closed
Sanofi
Phase 3
943
Murcia, Barcelona, Barakaldo, L'Hospitalet de Llobregat, Donostia / San Sebastian, Girona, Las Palmas de Gran Canaria, Lleida
2023-12-27
Recruiting
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT05581121Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
Institut Claudius Regaud
Phase 3
510
Barcelona, Girona, Madrid
2023-12-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Sabadell, Barcelona, Girona, A Coruña, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Burgos, Málaga
2023-12-18
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
DrugsElacestrant·Tamoxifen·Exemestane·Anastrozole
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Alicante, Barakaldo, El Palmar, Girona, Granada, L'Hospitalet de Llobregat, Lleida, Madrid
2023-12-15
Active, closed
Syndax Pharmaceuticals
Phase 2
145
L'Hospitalet de Llobregat, Sabadell, Santander, Majadahonda, Oviedo, Barcelona, Cadiz, Girona
2023-12-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
L'Hospitalet de Llobregat, Girona, Madrid, Valencia, Barcelona, Córdoba
2023-12-06
Recruiting
Institut d'Investigació Biomèdica de Bellvitge
Not applicable
90
Sant Joan d'Alacant, Castellon, Vigo, Barcelona, Girona, Santa Cruz de Tenerife, Valencia, Zaragoza
2023-11-22
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Exemestane·Anastrozole·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
510
Badajoz, Badalona, Manresa, Girona, León, Lleida, Madrid, Pamplona
2023-11-16
Active, closed
AstraZeneca
Phase 3
1,835
Girona, L'Hospitalet de Llobregat, Lugo, Madrid, Majadahonda, Seville, Valencia
2023-11-07
Active, closed
Summit Therapeutics
Phase 3
1,600
Badajoz, Badalona, Barcelona, Girona, Jaén, Las Palmas de Gran Canaria, Lugo, Madrid
2023-10-26
Recruiting
AstraZeneca
Phase 3
800
A Coruña, Barcelona, Córdoba, Girona, Hospitalet deLlobregat, Madrid, Palma de Mallorca, Valencia
2023-09-22
Active, closed
Ad scientiam
Not applicable
336
Girona, Madrid, Málaga, Oviedo, Zaragoza
2023-09-22
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Santander, Santiago de Compostela, Madrid, Majadahonda, Barcelona, Girona, Oviedo, Pamplona
2023-09-14
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
A Coruña, Barcelona, Córdoba, Girona, Granada, Valencia
2023-09-01
Recruiting
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain
NCT06068049Non-small Cell Lung Cancer
AstraZeneca
Observational
500
A Coruña, Alicante, Barcelona, C Rdoba, El Palmar, Girona, Granada, Jaén
2023-07-28
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Manises, Barcelona, Girona, Lleida, Lugo, Madrid, Seville
2023-07-06
Recruiting
Fundación Española de Hematología y Hemoterapía
Observational
210
Vitoria-Gasteiz, Almería, Palma de Mallorca, Sabadell, Burgos, Valdepeñas, Girona, Granada
2023-05-30
Active, closed
Grupo Espanol Multidisciplinario del Cancer Digestivo
Observational
120
Badalona, Terrassa, Madrid, Barcelona, Girona, Valencia, Zaragoza
2023-05-26
Active, closed
Fundación GECP
Phase 2
22
Alicante, Barcelona, Mataró, Bilbao, Cáceres, Jerez de la Frontera, Girona, Jaén
2023-05-12
Recruiting
SUPRAFLEX CRUZ PMCF Study ( rEpic05 )
NCT05617599Coronary Artery Disease (CAD), Ischemic Heart Disease
Fundación EPIC
Observational
508
Elche, A Coruña, Barakaldo, Barcelona, Castelló, Cáceres, Ciudad Real, Girona
2023-05-10
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT05440851Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High
University Health Network, Toronto
Not applicable
6,250
Ciutat Vella, Horta-Guinardó, L'Hospitalet de Llobregat, Sabadell, Girona, Santa Cruz de Tenerife
2023-04-30
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Donostia / San Sebastian, Zaragoza, Badalona, Barcelona, Córdoba, Girona, Granada, Madrid
2023-04-18
Active, closed
AbbVie
Phase 3
520
A Coruña, L'Hospitalet de Llobregat, Córdoba, Málaga, Pamplona, Barcelona, Girona, Madrid
2023-03-15
Recruiting
Post-market European & Asian Registry to Evaluate the Minos™ Stent-Graft and Delivery System in Abdominal Aortic Aneurysm Treatment
NCT07674173Endovascular Repair of Infrarenal Abdominal Aortic Aneurysm Using Endovascular Stent Graft
Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
Observational
200
Girona
2023-03-05
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
A Coruña, Albacete, Alicante, Badalona, Barakaldo, Barcelona, Córdoba, Girona
2023-02-15
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Córdoba, Santiago de Compostela, Las Palmas de Gran Canaria, Fuenlabrada, Barcelona, Girona, Huelva, Madrid
2023-01-16
Active, closed
Exelixis
Phase 3
317
Palma de Mallorca, Majadahonda, Barcelona, Córdoba, Girona, Madrid, Málaga, Oviedo
2023-01-01
Recruiting
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
NCT05751798Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)
OSE Immunotherapeutics
Phase 1/2
41
A Coruña, Girona, Málaga
2022-12-20
Recruiting
Iperboreal Pharma Srl
Phase 3
170
A Coruña, Badalona, Barcelona, Girona, Madrid, Oviedo
2022-12-14
Active, closed
Dizal Pharmaceuticals
Phase 3
324
Barcelona, A Coruña, Girona, Jerez de la Frontera, Madrid, Málaga, Seville, Valencia
2022-12-13
Recruiting
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Observational
116
Girona
2022-12-12
Recruiting
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Not applicable
40
Badalona, L'Hospitalet de Llobregat, Manresa, Sabadell, Sant Joan Despí, Terrassa, Cáceres, Girona
2022-11-29
Recruiting
Pfizer
Phase 3
1,060
Santiago de Compostela, Badalona, L'Hospitalet Del Llobregat, Terrassa, Santander, Barcelona, Girona, Madrid
2022-11-10
Active, closed
Fundación GECP
Phase 2
46
Alicante, Badalona, Barcelona, Bilbao, Girona, A Coruña, Lugo, Madrid
2022-11-07
Active, closed
Gilead Sciences
Phase 3
1,021
Barcelona, Córdoba, Girona, Jaén, Las Palmas de Gran Canaria, Madrid, Majadahonda, Reus
2022-10-12
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Barcelona, Ferrol, Girona, Madrid, Majadahonda, Seville, Vigo, Zaragoza
2022-09-27
Recruiting
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Not applicable
120
Girona
2022-08-31
Active, closed
AstraZeneca
Phase 3
341
Badajoz, Badalona, Barcelona, Córdoba, Girona, Madrid, Majadahonda, Málaga
2022-08-03
Active, closed
Incyte Corporation
Phase 1/2
53
Palma de Mallorca, Girona, L'Hospitalet de Llobregat, Madrid, Salamanca, Seville, Valencia
2022-07-19
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Córdoba, Badalona, Barcelona, Donostia / San Sebastian, El Palmar, Oviedo, A Coruña, Girona
2022-07-14
Active, closed
Fundación GECP
Observational
100
A Coruña, Alicante, Badalona, Barcelona, Bilbao, Córdoba, Girona, Pamplona
2022-06-17
Recruiting
Neck Evolution With Ovation in Spain
NCT05823519Abdominal Aortic Aneurysm
DGM Vascular
Observational
120
Palma de Mallorca, Girona, Barakaldo, Burgos, Salamanca, Toledo, Gijón, Barcelona
2022-06-01
Recruiting
Endoscopic Ultrasound-Guided Gastroenterostomy Nationwide: Prospective Registry.
NCT05128604Endoscopic Surgical Procedure, Safety, Training
Hospital Universitari de Bellvitge
Observational
50
Badalona, L'Hospitalet de Llobregat, Terrassa, Barcelona, Girona
2022-05-23
Recruiting
UNICANCER
Phase 3
300
Badalona, Barcelona, Girona, Madrid, Manresa, Valencia
2022-04-19
Active, closed
European Myeloma Network B.V.
Phase 3
117
Barcelona, Gijón, Girona, Madrid, Murcia, Pamplona, Salamanca, Santander
2022-04-19
By invitation
AstraZeneca
Phase 3
214
Barcelona, Girona, Madrid, Marbella, Santiago de Compostela, Valencia
2022-04-19
Recruiting
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Not applicable
36
Barcelona, Sabadell, Girona
2022-04-04
Active, closed
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Observational
138
Girona
2022-03-28
Recruiting
Fundación GECP
Phase 2
19
Alicante, Badalona, Barcelona, Bilbao, Girona, Granada, Jaén, A Coruña
2022-03-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Girona, Madrid, Valencia, Barcelona, Lugo, Málaga
2022-03-15
Active, closed
University Hospital, Basel, Switzerland
Not applicable
543
Barcelona, Girona, Madrid, Murcia, Valladolid
2021-12-09
Active, closed
Joseph Broderick, MD
Phase 3
860
Badalona, Horta, L'Hospitalet de Llobregat, Barcelona, Girona, Lleida
2021-12-03
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Sabadell, Pamplona, Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Málaga
2021-12-02
Active, closed
Gilead Sciences
Phase 3
603
A Coruña, Badalona, Barakaldo, Barcelona, Cáceres, Girona, Madrid, Málaga
2021-11-17
Active, closed
Camurus AB
Phase 3
332
A Coruña, Barcelona, Elche, Girona, Madrid, Málaga, Murcia, Oviedo
2021-10-22
Recruiting
Pfizer
Phase 3
893
Santiago de Compostela, L'Hospitalet Del Llobregat, Terrassa, Santander, Pamplona, Toledo, Barcelona, Girona
2021-10-04
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
NCT05059444Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma, Non-small Cell Lung Cancer
Guardant Health, Inc.
Observational
2,285
A Coruña, Barcelona, Girona, Las Palmas de Gran Canaria, Madrid, Málaga, Sabadell, Santiago de Compostela
2021-09-07
Recruiting
Philips Clinical & Medical Affairs Global
Not applicable
594
Madrid, Barcelona, Girona, Seville
2021-06-23
Active, closed
Incyte Corporation
Phase 3
899
Badalona, Barcelona, Girona, Jerez de la Frontera, Lugo, Madrid, Pamplona, Salamanca
2021-05-11
Recruiting
Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics
NCT05761080Laparoscopic Appendectomy, Complicated Appendicitis, Periappendicular Abscess
DrugMaximum
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 4
772
Barcelona, Córdoba, Lleida, Madrid, Seville, Badalona, Esplugues de Llobregat, Girona
2021-04-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Badalona, Manresa, Girona, Santiago de Compostela, Las Palmas de Gran Canaria, Oviedo, Valencia, Barcelona
2021-04-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Santander, Barcelona, Girona, Madrid, Málaga
2021-04-14
Recruiting
University Hospital of Girona Dr. Josep Trueta
Observational
100
Girona
2021-04-01
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Castellon, Barcelona, Córdoba, Girona, Madrid, Málaga, Seville, Valencia
2021-03-18
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Cáceres, Oviedo, Zaragoza, Badalona, Barcelona, Girona, Las Palmas de Gran Canaria, Lugo
2021-03-11
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Pamplona, A Coruña, Alicante, Badalona, Barakaldo, Barcelona, Córdoba, Girona
2021-02-23
Active, closed
New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy
NCT04564157Non-Small Cell Lung Cancer, Adjuvant Chemotherapy
DrugsParaplatin·Taxol·Opdivo·Nivolumab
Fundación GECP
Phase 3
210
Alicante, Badalona, Barcelona, L'Hospitalet de Llobregat, Bilbao, Cáceres, El Palmar, Girona
2021-01-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Girona, Madrid, Barcelona, Córdoba
2021-01-10
Active, closed
BioNTech SE
Phase 2/3
358
Barcelona, Girona, Jaén, Madrid, Majadahonda, Málaga, Palma de Mallorca, Valencia
2021-01-07
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
612
Santiago de Compostela, Girona, Madrid
2020-12-08
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
A Coruña, Badalona, Barcelona, Burgos, Girona, Madrid, Majadahonda, Málaga
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
696
A Coruña, Barcelona, Castellon, Girona, Jerez de la Frontera, Madrid, Málaga, Sabadell
2020-09-23
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
NCT04256317Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm, Chronic Myelomonocytic Leukemia
DrugsVenclexta·Azacitidine·Venetoclax
Taiho Oncology, Inc.
Phase 2/3
316
Badalona, L'Hospitalet de Llobregat, Pamplona, Oviedo, Barcelona, Cáceres, Girona, Granada
2020-05-21
Active, closed
AstraZeneca
Phase 3
805
Barcelona, El Palmar, Girona, Jaén, Madrid, Mallorca
2020-05-05
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Barcelona, L'Hospitalet de Llobregat, Girona, Madrid, Málaga, Pamplona, Zaragoza
2020-02-11
Active, closed
BeOne Medicines
Phase 3
955
Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Salamanca, Toledo
2020-01-16
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Barcelona, Girona, Lleida, Madrid, Palma, Tarragona, Valencia
2019-12-20
Active, closed
CStone Pharmaceuticals
Phase 3
534
A Coruña, Ourense, Majadahonda, Oviedo, Ávila, Barcelona, Burgos, Girona
2019-12-13
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Badalona, Barcelona, Girona, Madrid, Santander, Seville
2019-09-26
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
DrugsTulmimetostat·Enzalutamide
Novartis Pharmaceuticals
Phase 1/2
300
Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Majadahonda, Palma, Pamplona, Sabadell
2019-09-18
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
San Cristóbal de La Laguna, A Coruña, Alicante, Barcelona, Bilbao, Girona, Madrid, Málaga
2019-08-27
Active, closed
BeOne Medicines
Phase 3
510
Barcelona, Girona, Madrid, Málaga, Seville
2019-08-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Badalona, Barcelona, Cáceres, Girona, Pozuelo de Alarcón, Valencia, Madrid, Seville
2019-07-24
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Barcelona, Girona, Jerez de la Frontera, Madrid, Málaga, Seville, Valencia
2019-07-09
Active, closed
Grupo Español de Investigación en Cáncer de Ovario
Phase 2
134
Elche, Donostia / San Sebastian, Girona, Madrid, Vigo, Seville, Valencia, Barcelona
2019-06-28
Active, closed
NADIM II: Neo-Adjuvant Immunotherapy
NCT03838159Non Small Cell Lung Cancer
DrugsParaplatin·Taxol·Opdivo·Nivolumab
Fundación GECP
Phase 2
90
Alicante, Badalona, Barcelona, L'Hospitalet de Llobregat, Córdoba, Girona, Las Palmas de Gran Canaria, A Coruña
2019-05-15
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Barcelona, Girona, Madrid, Palma, Tarragona, Valencia
2019-03-01
Active, closed
AstraZeneca
Phase 3
895
Barcelona, Girona, Madrid, Málaga, Seville
2018-10-31
Active, closed
AbbVie
Phase 3
265
Palma de Mallorca, Marbella, Ourense, San Cristóbal de La Laguna, Barcelona, Girona, León, Madrid
2018-10-22
Active, closed
Tesaro, Inc.
Phase 3
1,400
Ávila, Badalona, Barcelona, Girona, Jaén, Madrid, Santiago de Compostela, Toledo
2018-10-11
Active, closed
Eli Lilly and Company
Phase 3
1,058
Alicante, Fuenlabrada, Girona, Huelva, Las Palmas de GC, Madrid, Oviedo, Sagunto
2018-07-18
Active, closed
PETHEMA Foundation
Phase 2
62
Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Murcia, Oviedo, Pamplona
2018-07-15
Active, closed
Corcept Therapeutics
Phase 2
125
Alicante, Girona, Madrid, Málaga, Seville
2018-05-07
Active, closed
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Barcelona, Castellon, Donostia / San Sebastian, Girona, Madrid, Vigo
2018-05-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Badalona, L'Hospitalet de Llobregat, Girona, Las Palmas de Gran Canaria, Barcelona, Madrid, Seville
2018-04-24
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Córdoba, Ferrol, Girona, Huelva, Madrid, Oviedo, Pontevedra, Seville
2018-04-13
Active, closed
AbbVie
Phase 3
747
Palma de Mallorca, Santander, Las Palmas de Gran Canaria, Pamplona, A Coruña, Barcelona, Girona, Huelva
2018-03-21
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
L'Hospitalet de Llobregat, Barcelona, Elche, Girona, Madrid, Málaga, Valencia, Valladolid
2017-05-03
Active, closed
Pfizer
Phase 3
296
L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Majadahonda, Pamplona, A Coruña, Barcelona, Girona, Madrid
2017-04-27
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Barcelona, Girona, Madrid, Pamplona, Salamanca, Santiago de Compostela
2016-12-22
Active, closed
Tesaro, Inc.
Phase 3
733
Badalona, Barcelona, Córdoba, Donostia / San Sebastian, Elche Alicante, Girona, Madrid, Seville
2016-07-11
Active, closed
Tesaro, Inc.
Phase 1
463
Barcelona, Girona, Jerez de la Frontera, L'Hospitalet de Llobrega, Las Palmas de Gran Canar, Madrid, Málaga, Palma de Mallorca
2016-07-08
Active, closed
Tesaro, Inc.
Phase 1
729
Santiago de Compostela, Barcelona, Girona, Madrid, Málaga, Murcia, Pamplona, Santander
2016-03-07
Active, closed
AstraZeneca
Phase 3
1,118
A Coruña, Alicante, Barcelona, Girona, Jaén, León, Madrid, Majadahonda
2015-07-21
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Girona, Pamplona, Madrid
2015-07-14
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Palma de Mallorca, Manresa, Santiago de Compostela, Barcelona, Cadiz, Girona, Madrid, Ourense
2014-12-17
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
El Palmar, Barcelona, Donostia / San Sebastian, Girona, Madrid, Málaga, Oviedo, Palma
2014-12-04
Active, closed
UNICANCER
Phase 3
1,173
Badalona, Barcelona, Girona, Madrid, Manresa, Málaga, Sabadell, Salamanca
2013-11-13
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
A Coruña, Badalona, Barcelona, Castellon, Girona, Guadalajara, Jerez de la Frontera, Las Palmas de Gran Canaria
2013-10-14
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Barcelona, Córdoba, Girona, Madrid, Pamplona, Valencia
2013-09-03
Recruiting
3D Laparoscopic Adrenalectomies for Adrenal Tumors
NCT04905706Adrenal Tumor, Adrenalectomy; Status
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Observational
300
Girona
2013-01-01
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
A Coruña, Córdoba, Elche, Girona, Granada, L'Hospitalet de Llobregat, Madrid, Málaga
2012-01
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
5,018
A Coruña, Albacete, Barcelona, Castellon, Cáceres, Donostia / San Sebastian, Girona, Madrid
2011-02-28
Recruiting
International Registry of Accidental Hypothermia
NCT06200285Accidental Hypothermia
University Hospital, Geneva
Observational
500
Barcelona, Girona
2008-10-01
Recruiting
Medtronic
Observational
20,000
A Coruña, Barcelona, Córdoba, Girona, Granada, Madrid, Palma de Mallorca, Salamanca
1983-01
Rows per page Showing 1–213 of 213
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/girona

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 213 of those studies with a site in Girona.

How many clinical trials are recruiting in Girona?

113 of the 213 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 96 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Girona), 213 studies
PhaseStudiesRecruitingShare
Phase 31084350.7%
Phase 2322015%
Not applicable241611.3%
Observational241911.3%
Phase 2/31064.7%
Phase 1/2853.8%
Phase 4431.9%
Phase 1311.4%

Most active sponsors

Lead sponsors with the most studies (Girona)
Lead sponsorStudiesRecruiting
AstraZeneca177
Merck Sharp & Dohme LLC168
Fundación GECP94
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta98
Janssen Research & Development, LLC83
Pfizer64
MedSIR54
AbbVie41
Stichting Hemato-Oncologie voor Volwassenen Nederland42
Tesaro, Inc.40
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.